Welcome to Resiliency Radio with Dr. Jill Carnahan, where today's episode explores one of the most debated and rapidly evolving topics in environmental medicine: Therapeutic Plasma Exchange (TPE) for toxic mold illness and chronic inflammatory syndromes.

Dr. Jill is joined by Dr. Paul Savage, founder of MDLifespan, to break down the science, safety, and real-world application of TPE and the patent-pending PlasmaXchange™ protocol.

For many patients struggling with persistent mold toxicity, autoimmune flares, chronic inflammation, and toxic burden, traditional detox strategies—binders, sauna, fasting, chelation—may not be enough. This episode provides an evidence-informed, transparent Q&A exploring whether Therapeutic Plasma Exchange could be a missing link in complex recovery cases.

Together, they examine what TPE actually removes from the bloodstream, who may benefit most, potential risks and contraindications, and how clinicians measure outcomes before and after treatment.

✨ Like, subscribe, and share to help more patients and practitioners understand advanced options for toxic mold and environmental illness recovery.

🔑 Key Discussions – What You'll Learn

① What Is Therapeutic Plasma Exchange (TPE)? ⇨ What is physically removed during the procedure—free toxins, protein-bound toxins, inflammatory cytokines, immune complexes—and what is returned.

② How TPE Reduces Toxic Burden Mechanistically ⇨ The difference between removing circulating toxins versus mobilizing stored toxins—and why this distinction matters.

③ Who May Benefit Most from TPE ⇨ Mold illness, persistent inflammatory syndromes, autoimmune flares, complex toxic load, and medication-resistant cases.

④ Safety, Contraindications & Risk Mitigation ⇨ Who is not an ideal candidate, potential side effects, rare risks, and the importance of proper screening.

⑤ Is TPE a Reset or Long-Term Strategy? ⇨ How many sessions are typically needed, what "removing up to 90% of circulating toxins" actually means, and whether TPE should be viewed as a bridge or foundational intervention.

⭐ Key Takeaways ⇨ TPE removes circulating inflammatory mediators and toxin-bound plasma components ⇨ It may benefit patients with severe or persistent toxic mold illness ⇨ Proper patient selection and medical supervision are critical ⇨ Objective biomarkers help track effectiveness ⇨ TPE may function as a reset within a broader long-term recovery plan

👨‍⚕️ Guest Biography

Dr. Paul Savage, M.D., FACEP, FAARM, is a physician, innovator, and founder of MDLifespan, where he serves as Chief Medical Officer and leads development of the patent-pending PlasmaXchange™ protocols focused on reducing environmental toxins and enhancing long-term vitality.

With more than 35 years of clinical experience, Dr. Savage transitioned from emergency medicine into integrative, personalized longevity care after transforming his own health through lifestyle medicine, hormone optimization, and regenerative therapies. He is also the founder of the national hormone therapy network BodyLogicMD and is a recognized leader in precision longevity and biomarker-driven medicine.

🔗 Learn more: http://www.mdlifespan.com/drjill